Prostate Cancer Clinical Trial
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population
Summary
The goal of the study is to provide a detailed description of treatments for CRPC (Castrate Resistant Prostate Cancer) patients with bone metastases and the resource utilization and costs associated with that diagnosis and subsequent treatments.
Eligibility Criteria
Inclusion Criteria:
First diagnosis for bone metastases for members diagnosed with prostate cancer found in the claims data during the identification period
Members age ≥ 55 to 89 years at index
Medicare members with medical and pharmacy coverage; and
Continuously enrolled during the pre- and post-index periods.
Exclusion Criteria:
Member with diagnosis of any other cancer (excluding melanoma (ICD-9 172.x) and other metastases (ICD-9 198.x)) before the index date; and
Members age ≥ 89 years of age at index date
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Louisville Kentucky, , United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.